4
Assessment
Figure
1.
ACC/AHA
Stages
of
HF
Patients
at
risk
for
HF
but
without
current
or
previous
symptoms/
signs
of
HF
and
without
structural/functional
heart
disease
or
abnormal
biomarkers
Patients
with
hypertension,
CVD,
diabetes,
obesity,
exposure
to
cardiotoxic
agents,
genetic
variant
for
cardiomyopathy,
or
family
history
of
cardiomyopathy
Patients
without
current
or
previous
symptoms/
signs
of
HF
but
evidence
of
1
of
the
following:
Structural
heart
disease Evidence
of
increased
filling
pressures
Risk
factors
and
•
increased
natriuretic
peptide
levels
or
•
persistently
elevated
cardiac
troponin
in
the
absence
of
competing
diagnoses
Patients
with
current
or
previous
symptoms/
signs
of
HF
Marked
HF
symptoms
that
interfere
with
daily
life
and
with
recurrent
hospitalizations
despite
attempts
to
optimize
GDMT
